PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
[Image: see text] Identification of HLA class I ligands from the tumor surface (ligandome or immunopeptidome) is essential for designing T-cell mediated cancer therapeutic approaches. However, the sensitivity of the process for isolating MHC-I restricted tumor-specific peptides has been the major li...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552492/ https://www.ncbi.nlm.nih.gov/pubmed/34605646 http://dx.doi.org/10.1021/acsnano.1c04371 |